로딩 중…
지수 로딩 중…
Peptron
087010· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩204,500-5.54%
2026-06-19
Price Chart
Peptron+2.40%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 4.77T KRW |
| Revenue | 5.98B KRW |
| Net Income | -7.47B KRW |
| Total Assets | 174.46B KRW |
| Net Assets | 135.97B KRW |
| Employees | 112 |
| Value | |
| P/B | 35.07x |
| P/S | 797.23x |
| FCF Yield | -0.48% |
| Profitability | |
| ROE | -5.50% |
| ROA | -4.28% |
| Op. Margin | -379.24% |
| Revenue Growth | 21.38% |
| Financial Health | |
| Debt Ratio | 128.30% |
| Total Debt | 29.68B KRW |
| FCF | -23.08B KRW |
| Cash | 10.59B KRW |
| Current Ratio | 12.19x |
| Performance | |
| 1Y Return | 2.40% |
| 1M Return | -12.61% |
| From 52W High | -47.90% |
| 1Y MDD | -47.02% |
| Trading | |
| Volume | 242,208 shares |
| Foreign Own. | 5.28% |
| Per Share | |
| EPS | -713 KRW |
| BPS | 5,850 KRW |
Company Info
Peptron, established in 1997 for biotechnology advanced material manufacturing and pharmaceutical R&D, was listed on KOSDAQ in 2015. The company develops pharmaceuticals based on peptide engineering and drug efficacy sustaining original technology, securing clinical trial and commercialization capabilities through GMP mass production facilities. With its SmartDepot technology, Peptron can develop various pharmaceuticals, accelerate its contract drug development and manufacturing business, and conduct research on metabolic disease treatments and anticancer drugs. The company is headquartered in Yuseong-gu, Daejeon.